» Articles » PMID: 37433295

Inhibition of Nucleolar Transcription by Oxaliplatin Involves ATM/ATR Kinase Signaling

Overview
Journal Cell Chem Biol
Publisher Cell Press
Specialty Biochemistry
Date 2023 Jul 11
PMID 37433295
Authors
Affiliations
Soon will be listed here.
Abstract

Platinum (Pt) compounds are an important class of anti-cancer therapeutics, but outstanding questions remain regarding their mechanism of action. Here, we demonstrate that oxaliplatin, a Pt drug used to treat colorectal cancer, inhibits rRNA transcription through ATM and ATR signaling, and induces DNA damage and nucleolar disruption. We show that oxaliplatin causes nucleolar accumulation of the nucleolar DNA damage response proteins (n-DDR) NBS1 and TOPBP1; however transcriptional inhibition does not depend upon NBS1 or TOPBP1, nor does oxaliplatin induce substantial amounts of nucleolar DNA damage, distinguishing the nucleolar response from previously characterized n-DDR pathways. Taken together, our work indicates that oxaliplatin induces a distinct ATM and ATR signaling pathway that functions to inhibit Pol I transcription in the absence of direct nucleolar DNA damage, demonstrating how nucleolar stress and transcriptional silencing can be linked to DNA damage signaling and highlighting an important mechanism of Pt drug cytotoxicity.

Citing Articles

The unique Pt(II)-induced nucleolar stress response and its deviation from DNA damage response pathways.

Pigg H, Alley K, Griffin C, Moon C, Kraske S, DeRose V J Biol Chem. 2024; 300(11):107858.

PMID: 39374783 PMC: 11612370. DOI: 10.1016/j.jbc.2024.107858.


WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.

Zhang X, Sun K, Gan R, Yan Y, Zhang C, Zheng D BMC Cancer. 2024; 24(1):564.

PMID: 38711026 PMC: 11071218. DOI: 10.1186/s12885-024-12318-2.


Click-Capable Phenanthriplatin Derivatives as Tools to Study Pt(II)-Induced Nucleolar Stress.

ODowd P, Guerrero A, Alley K, Pigg H, ONeill F, Meiller J ACS Chem Biol. 2024; 19(4):875-885.

PMID: 38483263 PMC: 11040607. DOI: 10.1021/acschembio.3c00607.


Comparison of click-capable oxaliplatin and cisplatin derivatives to better understand Pt(ii)-induced nucleolar stress.

Guerrero A, ODowd P, Pigg H, Alley K, Griffith D, DeRose V RSC Chem Biol. 2023; 4(10):785-793.

PMID: 37799581 PMC: 10549245. DOI: 10.1039/d3cb00055a.

References
1.
Rijal K, Chow C . A new role for cisplatin: probing ribosomal RNA structure. Chem Commun (Camb). 2008; (1):107-9. DOI: 10.1039/b816633a. View

2.
Pefani D, Tognoli M, Pirincci Ercan D, Gorgoulis V, ONeill E . MST2 kinase suppresses rDNA transcription in response to DNA damage by phosphorylating nucleolar histone H2B. EMBO J. 2018; 37(15). PMC: 6068430. DOI: 10.15252/embj.201798760. View

3.
Hostetter A, Osborn M, DeRose V . RNA-Pt adducts following cisplatin treatment of Saccharomyces cerevisiae. ACS Chem Biol. 2011; 7(1):218-25. PMC: 3262962. DOI: 10.1021/cb200279p. View

4.
van Sluis M, McStay B . A localized nucleolar DNA damage response facilitates recruitment of the homology-directed repair machinery independent of cell cycle stage. Genes Dev. 2015; 29(11):1151-63. PMC: 4470283. DOI: 10.1101/gad.260703.115. View

5.
Andrews W, Panova T, Normand C, Gadal O, Tikhonova I, Panov K . Old drug, new target: ellipticines selectively inhibit RNA polymerase I transcription. J Biol Chem. 2013; 288(7):4567-82. PMC: 3576063. DOI: 10.1074/jbc.M112.411611. View